Anesthesia for functional neurosurgery: The role of dexmedetomidine

Current Opinion in Anaesthesiology

Volumn 21, Issue 5, 2008, Pages 537-543

  Rozet, Irene ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Awake craniotomy; Dexmedetomidine; Implantation of deep brain stimulator

Indexed keywords

BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CLONIDINE; DEXMEDETOMIDINE; DROPERIDOL; FENTANYL; INHALATION ANESTHETIC AGENT; MIDAZOLAM; OPIATE; OXYGEN; PROPOFOL; REMIFENTANIL;

ANESTHESIA; BLOOD PRESSURE; BRADYCARDIA; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN MAPPING; CONTINUOUS INFUSION; CRANIOTOMY; DRUG DOSE TITRATION; DRUG HALF LIFE; HUMAN; INHALATION ANESTHESIA; METABOLIC RATE; MICROELECTRODE; NEUROPROTECTION; NEUROSURGERY; NONHUMAN; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW; SEDATION; SLEEP; VASOCONSTRICTION; VASODILATATION;

ADRENERGIC ALPHA-AGONISTS; ANESTHESIA; CONSCIOUS SEDATION; CONSCIOUSNESS; DEEP BRAIN STIMULATION; DEXMEDETOMIDINE; HUMANS; NEUROSURGICAL PROCEDURES; POSTURE; RISK FACTORS; TREATMENT OUTCOME;

EID: 53549099664     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e32830edafd     Document Type: Review

References (42)

1. Erickson KM, Cole DJ. Anesthetic considerations for awake craniotomy for epilepsy. Anesthesiol Clin 2007; 25:535-555.
2. Ayoub C, Girard F, Boudreault D, et al. A comparison between scalp nerve block and morphine for transitional analgesia after remifentanil-based anesthesia in neurosurgery. Anesth Analg 2006; 103:1237-1240.
3. Skucas AP, Artru AA. Anesthetic complications of awake craniotomies for epilepsy surgery. Anesth Analg 2006; 102:882-887.
4. Manninen PH, Balki M, Lukitto K, Bernstein M. Patient satisfaction with awake craniotomy for tumor surgery: a comparison of remifentanil and fentanyl in conjunction with propofol. Anesth Analg 2006; 102:237-242.
5. Venkatraghavan L, Manninen P, Mak P, et al. Anesthesia for functional neurosurgery: review of complications. J Neurosurg Anesthesiol 2006; 18:64-67.
6. Khatib R, Ebrahim Z, Rezai A, et al. Perioperative events during deep brain stimulation: the experience at Cleveland clinic. J Neurosurg Anesthesiol 2008; 20:36-40.
7. Santos P, Valero R, Arguis MJ, et al. Preoperative adverse events during stereotactic microelectrode-guided deep brain surgery in Parkinson's disease. Rev Esp Anestesiol Reanim 2004; 51:523-530.
8. Deep-Brain Stimulation for Parkinson's Disease Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001; 345:956-963.
9. Tir M, Devos D, Blond S, et al. Exhaustive, one-year follow-up of subthalamic nucleus deep brain stimulation in a large, single-center cohort of parkinsonian patients. Neurosurgery 2007; 61:297-304.
10. Binder DK, Rau GM, Starr PA. Risk factors for hemorrhage during microelectrode-guided deep brain stimulator implantation for movement disorders. Neurosurgery 2005; 56:722-732.
11. Fabregas N, Rapado J, Gambus PL, et al. Modeling of the sedative and airway obstruction effects of propofol in patients with Parkinson disease undergoing stereotactic surgery. Anesthesiology 2002; 97:1378-1386.
12. Lobo F, Beiras A. Propofol and remifentanil effect-site concentrations estimated by pharmacokinetic simulation and bispectral index monitoring during craniotomy with intraoperative awakening for brain tumor resection. J Neurosurg Anesthesiol 2007; 19:183-189.
13. Velly U, Rey MF, Bruder NJ, et al. Differential dynamic of action on cortical and subcortical structures of anesthetic agents during induction of anesthesia. Anesthesiology 2007; 107:202-212.
14. Alkire MT, McReynolds JR, Hahn EL, Trivedi AN. Thalamic microinjection of nicotine reverses sevoflurane-induced loss of righting reflex in the rat. Anesthesiology 2007; 107:264-272.
15. Hoffman WE, Kochs E, Werner C, et al. Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Reversal by the alpha 2-adrenergic antagonist atipamezole. Anesthesiology 1991; 75:328-332.
16. Kuhmonen J, Pokorny J, Miettinen R, et al. Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischemia. Anesthesiology 1997; 87:371-377.
17. Kuhmonen J, Haapalinna A, Sivenius J. Effects of dexmedetomidine after transient and permanent occlusion of the middle cerebral artery in the rat. J Neural Transm 2001; 108:261-271.
18. Dahmani S, Paris A, Jannier V, et al. Dexmedetomidine increases hippocampal phosphorylated extracellular signal-regulated protein kinase 1 and 2 content by an alpha 2-adrenoceptor-independent mechanism: evidence for the involvement of imidazoline 11 receptors. Anesthesiology 2008; 108:457-466.
19. Bryan RM Jr, Steenberg ML, Eichler MY, et al. Permissive role of NO in alpha 2-adrenoceptor-mediated dilations in rat cerebral arteries. Am J Physiol 1995; 269:1171-1174.
20. Bryan RM Jr, Eichler MY, Swafford MW, et al. Stimulation of alpha 2 adrenoceptors dilates the rat middle cerebral artery. Anesthesiology 1996; 85:82-90.
21. lida H, Ohata H, lida M, et al. Direct effects of alphal-and alpha2-adrenergic agonists on spinal and cerebral pial vessels in dogs. Anesthesiology 1999; 91:479-485.
22. Ganjoo P, Farber NE, Hudetz A, et al. In vivo effects of dexmedetomidine on laser-Doppler flow and pial arteriolar diameter. Anesthesiology 1998; 88:429-439.
23. Ishiyama T, Dohi S, lida H, et al. Mechanisms of dexmedetomidine-induced cerebrovascular effects in canine in vivo experiments. Anesth Analg 1995; 81:1208-1215.
24. lida H, lida M, Ohata H, et al. Hypothermia attenuates the vasodilator effects of dexmedetomidine on pial vessels in rabbits in vivo. Anesth Analg 2004; 98:477-482.
25. Prielipp RC, Wall MH, Tobin JR, et al. Dexmedetomidine-induced sedation in volunteers decreases regional and global cerebral blood flow. Anesth Analg 2002; 95:1052-1059.
26. Drummond JC, Dao AV, Roth DM, et al. Effect of dexmedetomidine on cerebral blood flow velocity, cerebral metabolic rate, and carbon dioxide response in normal humans. Anesthesiology 2008; 108:225-232.
27. Zornow MH, Fleischer JE, Scheller MS, et al. Dexmedetomidine, an alpha 2-adrenergic agonist, decreases cerebral blood flow in the isoflurane-anesthetized dog. Anesth Analg 1990; 70:624-630.
28. Mirski MA, Rossell LA, McPherson RW, Traystman RJ. Dexmedetomidine decreases seizure threshold in a rat model of experimental generalized epilepsy. Anesthesiology 1994; 81:1422-1428.
29. Whittington RA, Virag L, Vulliemoz Y, et al. Dexmedetomidine increases the cocaine seizure threshold in rats. Anesthesiology 2002; 97:693-700.
30. Tanaka K, Oda Y, Funao T, et al. Dexmedetomidine decreases the convulsive potency of bupivacaine and levobupivacaine in rats: involvement of alpha2-adrenoceptor for controlling convulsions. Anesth Analg 2005; 100:687-696.
31. Halonen T, Kotti T, Tuunanen J, et al. Alpha 2-adrenoceptor agonist, dexmedetomidine, protects against kainic acid-induced convulsions and neuronal damage. Brain Res 1995; 693:217-224.
32. Nelson LE, Lu J, Guo T, et al. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology 2003; 98:428-436.
33. Hsu YW, Cortinez LI, Robertson KM, et al. Dexmedetomidine pharmacodynamics: part I: crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology 2004; 101: 1066-1076.
34. Bekker AY, Kaufman B, Samir H, Doyle W. The use of dexmedetomidine infusion for awake craniotomy. Anesth Analg 2001; 92:1251-1253.
35. Bustillo MA, Lazar RM, Finck AD, et al. Dexmedetomidine may impair cognitive testing during endovascular embolization of cerebral arteriovenous malformations: a retrospective case report series. J Neurosurg Anesthesiol 2002; 14:209-212.
36. Ard JL Jr, Bekker AY, Doyle WK. Dexmedetomidine in awake craniotomy: a technical note. Surg Neurol 2005; 63:114-116.
37. Souter MJ, Rozet I, Ojemann JG, et al. Dexmedetomidine sedation during awake craniotomy for seizure resection: effects on electrocorticography. J Neurosurg Anesthesiol 2007; 19:38-44.
38. Rozet I, Muangman S, Vavilala MS, et al. Clinical experience with dexmedetomidine for implantation of deep brain stimulators in Parkinson's disease. Anesth Analg 2006; 103:1224-1228.
39. Talke P, Stapelfeldt C, Garcia P. Dexmedetomidine does not reduce epilepti-form discharges in adults with epilepsy. J Neurosurg Anesthesiol 2007; 19:195-199.
40. Oda Y, Toriyama S, Tanaka K, et al. The effect of dexmedetomidine on electrocorticography in patients with temporal lobe epilepsy under sevoflur-ane anesthesia. Anesth Analg 2007; 105:1272-1277.
41. Elias WJ, Durieux ME, Huss D, Frysinger RC. Dexmedetomidine and arousal affect subthalamic neurons. Mov Disord 2008.
42. Deogaonkar A, Deogaonkar M, Lee JY, et al. Propofol-induced dyskinesias controlled with dexmedetomidine during deep brain stimulation surgery. Anesthesiology 2006; 104:1337-1339.